For the week, the Dow Jones Industrial Average dropped 1,721
points closing at 25,605.54. The S&P 500 fell 167 points to 3040.31 while
the Nasdaq Composite fell 248 points to 9,588.81. The sell-off this week mostly
took place on Thursday, the worst day for the market since March, when the news
was confirmed about the new cases and hospitalizations.
ETFG Fund Flow Summary - In ETFs, we saw outflows from some of the large
geographic-focused ETFs. BBEU,
the JPMorgan BetaBuilders Europe ETF, lost over $1.4B in assets during this
week. That was followed by BBJP,
the JPMorgan BetaBuilders Japan ETF, which shed about $1B in assets. In inflows,
we saw investors move their assets to Sector based ETFs. XLF, the Financial Select
Sector SPDR ETF, saw some of the greatest inflows for the week, gaining over $3.5B
in AUM. That was followed by XLV,
the Health Care Select Sector SPDR ETF, which gained over $2.25B in assets.
ETFG Weekly Select List - The five most highly rated ETFs per Sector, Geographic Region and
Strategy as ranked by the ETFG Quant model.
Because of this strategy’s success, we highlight some
substantial movement in the Health Care portion of this week’s Select List to
last. The SPDR S&P Biotech ETF, XBI, held steady at the top
spot on the list. Following that was FHLC, the Fidelity MSCI
Health Care Index ETF and JHMH,
the John Hancock Multifactor Healthcare ETF, which moved up one spot from last
week. Rounding out the list this week was BBH, VanEck Vectors Biotech
ETF and PPH, VanEck
Vectors Pharmaceutical ETF, which finished 4th and 5th on
the list respectively.
We will continue to pay close attention to the new data
coming out this week on new coronavirus cases. Though many government leaders
were urging not to panic over the numbers, the thought of diving fully back
into stay-at-home orders will be enough to keep volatility churning in the
marketplace.
Thanks for reading ETF Global
Perspectives!
ETFG 21 Day Free Trial: https://www.etfg.com/signup/quick
_______________________________________________________
Assumptions, opinions and estimates constitute our judgment as of
the date of this material and are subject to change without notice. ETF Global LLC (“ETFG”) and its affiliates
and any third-party providers, as well as their directors, officers,
shareholders, employees or agents (collectively ETFG Parties) do not guarantee
the accuracy, completeness, adequacy or timeliness of any information,
including ratings and rankings and are not responsible for errors and omissions
or for the results obtained from the use of such information and ETFG Parties
shall have no liability for any errors, omissions, or interruptions therein,
regardless of the cause, or for the results obtained from the use of such
information. ETFG PARTIES DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES,
INCLUDING, BUT NOT LIMITED TO ANY WARRANTIES OF MERCHANTABILITY, SUITABILITY OR
FITNESS FOR A PARTICULAR PURPOSE OR USE.
In no event shall ETFG Parties be liable to any party for any
direct, indirect, incidental, exemplary, compensatory, punitive, special or
consequential damages, costs, expenses, legal fees, or losses (including,
without limitation, lost income or lost profits and opportunity costs) in
connection with any use of the information contained in this document even if
advised of the possibility of such damages.
ETFG ratings and rankings are statements of opinion as of the date
they are expressed and not statements of fact or recommendations to purchase,
hold, or sell any securities or to make any investment decisions. ETFG ratings
and rankings should not be relied on when making any investment or other
business decision. ETFG’s opinions and
analyses do not address the suitability of any security. ETFG does not act as a fiduciary or an
investment advisor. While ETFG has
obtained information from sources they believe to be reliable, ETFG does not
perform an audit or undertake any duty of due diligence or independent
verification of any information it receives.
This material is not intended as an offer or solicitation for the
purchase or sale of any security or other financial instrument. Securities,
financial instruments or strategies mentioned herein may not be suitable for
all investors. Any opinions expressed
herein are given in good faith, are subject to change without notice, and are
only correct as of the stated date of their issue. Prices, values, or income from any securities
or investments mentioned in this report may fall against the interests of the
investor and the investor may get back less than the amount invested. Where an investment is described as being
likely to yield income, please note that the amount of income that the investor
will receive from such an investment may fluctuate. Where an investment or security is
denominated in a different currency to the investor's currency of reference,
changes in rates of exchange may have an adverse effect on the value, price or
income.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.